NIVABUPA
NIVA BUPA HEALTH INS CO L
Each stock's 10,000-path forecast, rendered as light.
NIVA BUPA HEALTH INS CO L (NIVABUPA) Stock Analysis & Case Study
Is NIVABUPA a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 50/100.
On the numbers, NIVA BUPA HEALTH INS CO L (NIVABUPA) mixed signals, a Downstox Snapshot Score of 50/100, weighing a 53% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
NIVABUPA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.6y of NIVABUPA history (10%/yr drift, 37%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| NIVABUPA 2027 | ₹55 | ₹90 | ₹145 | +3% |
| NIVABUPA 2028 | ₹47 | ₹92 | ₹182 | +6% |
| NIVABUPA 2029 | ₹42 | ₹95 | ₹218 | +9% |
| NIVABUPA 2030 | ₹37 | ₹98 | ₹256 | +13% |
| NIVABUPA 2031 | ₹34 | ₹101 | ₹297 | +16% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability NIVABUPA goes up, or doubles?
The bull case for NIVABUPA
- NIVA BUPA HEALTH INS CO L is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹218.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹42.
NIVABUPA volatility & expected range, how bumpy is the ride?
Over the last 1.6 years NIVABUPA compounded at 10%/year with annualized volatility of 37%. That volatility implies a 1-year 80% range of ₹55–₹145, the honest backbone behind any single price target.
NIVABUPA price forecast, the full 60-month probability fan
NIVABUPA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NIVABUPA hits common targets within the simulated horizon?
Full multi-horizon detail on the NIVABUPA price target & forecast page.
NIVABUPA MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy NIVABUPA with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 29.0% | 3.4× |
| ZerodhaCHEAPEST | 29.0% | 3.4× |
| DhanCHEAPEST | 29.0% | 3.4× |
Compare every broker on the NIVABUPA MTF page.
NIVABUPA vs peers,sector comparison
About NIVA BUPA HEALTH INS CO L: sector, index & market-cap context
NIVA BUPA HEALTH INS CO L (NIVABUPA) is an NSE-listed company.
How the NIVABUPA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of NIVA BUPA HEALTH INS CO L's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
NIVABUPA analysis, FAQs
Is NIVA BUPA HEALTH INS CO L (NIVABUPA) a good buy?
On the numbers, NIVA BUPA HEALTH INS CO L (NIVABUPA) mixed signals, a Downstox Snapshot Score of 50/100, weighing a 53% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is NIVABUPA overvalued or undervalued?
Valuation ratios for NIVABUPA are tracked live on Downstox.
What is the NIVABUPA share price target for 2031?
NIVABUPA's probability-weighted 2031 median target is ₹101, with an 80% range of ₹34–₹297 (10,000-path Monte-Carlo).
What is the probability NIVABUPA doubles in 5 years?
The modelled probability of NIVABUPA reaching ₹174 (2×) within 5 years is 26%.
What is the bull case for NIVABUPA?
NIVA BUPA HEALTH INS CO L is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in NIVABUPA?
No model or past record guarantees future returns, treat this as one input, not a decision.